Loading...

EPIGRAL Epigral Ltd Earnings Reports Announcement

pgrl

PGRL

Epigral Ltd

(EPIGRAL)

2025 Announcement

Show Summary

Summary

Q1 FY26 Results

Investor Presentation

Conference Call Notice

Investor Meeting

Investor Meeting

Compliance Certificate

Renewable Energy Acquisition

Annual General Meeting

Annual Compliance Report

Promoter Reclassification

Investor Conference

Record Earnings Results

Financial Results Publication

No Fund Deviation

Conference Call Update

Monitoring Agency Report

Q4 FY2025 Results

Investor Presentation

Conference Call Notice

Postal Ballot Notice

Compliance Certificate

Chlorotoluenes Facility

Investor Meeting

Investor Meeting

Credit Rating Upgrade

Investor Meeting

Director Change

Investor Conference Notice

Investor Meet Scheduled

Q3 FY25 Results

Dividend Record Date

Financial Results Published

Q3 FY25 Results

Fund Utilization Update

Monitoring Report Submitted

Q3 FY2025 Results

Investor Presentation

Analyst Call Announcement

Compliance Certificate

RTA Name Change

Investor Meet Scheduled

Credit Rating Update

Reclassification Withdrawal

Investor Meeting

Investor Meeting

Investor Conference

Q2 FY25 Results

Conference Call Update

Investor Conference

Financial Results Release

Financial Growth & Expansion

Investor Presentation

Production Capacity Expansion

Conference Call Update

Conference Call Notice

Equity Share Allotment

Equity Shares Allotment

Fundraising Approval

Investor Meet Scheduled

Regulatory Compliance

Investor Meeting

Investor Meet Scheduled

Investor Meeting

Investor Conference

Investor Meeting

Investor Plant Visit

Investor Conference

Investor Meeting

Investor Meeting Notice

Investor Visit Planned

Postal Ballot Notice

Fundraising Announcement

Participation in Conference

Investor Meeting

Investor/Analyst Meet

Financial Results Publication

Earnings Call Audio Recording

Investor Presentation

Financial Results

Conference Call

Compliance Certificate

Updates Notification

CPVC Compound Plant Commiss...

Investor Meeting

One-on-One VC Intimation

Meeting Intimation

AGM Publication

Investor Conference

Meeting Intimation

Compliance Submission

Meeting Intimation

Meeting Intimation

Financial Results Publication

Investor Meeting

Appointment of Officer

Resignation Announcement

Financial Results

Investor Presentation

Certificate Submission

Conference Call

Certificate Submission

Compliance Confirmation

Expansion of CPVC Resin Cap...

Recognition Registration DSIR

Meeting Intimation

One-on-One Meeting

Clarification Announcement

Meeting Intimation

One-on-One Meeting

Conference Call

Earnings Conference Call

Earnings Presentation

Financial Results

Earnings Conference Call

Investor Conference

Regulatory Compliance

Meeting Intimation

Investor Conference

Meeting with Institutional ...

Investor Meeting

Investor/Analyst Plant Visi...

Investor/Analyst Plant Visit

Credit Rating Reaffirmment

R&D Centre Opening

Earnings Conference Call

Newspaper Publication

Audio Recording of Earnings...

Earnings Presentation

Financial Results

Investor Conferences

Investor Meetings

Participation in Conferences

Participation in Conferences

Certificate Submission

Corporate presentation

Investor Meeting

Scheduled Meetings

Investor Meetings

One-on-one VC Meetings

Meeting with Matthews Inter...

One-on-one Meeting

CPVC Compound Manufacturing...

Meeting with JM Financial S...

Participation in Conference

Analyst Meetings

Presentation and meetings

Conference Participation

Reclassification of Promote...

Financial Statements

Investor Meetings

Earnings Releases

Conference Call

Investor Meetings

Geographic Expansion

VC with Analyst/Fund Manager

One-on-one Meeting

Investor Meetings

Investor Meetings

One-on-one Meetings

Analyst/Fund Manager Meeting

Shareholder reclassification

Analyst Meeting

Analyst Meeting

Annual General Meeting

Management Changes

Management Changes

External Links:

Data:

Epigral Ltd announced its Q3 FY2025 un-audited financial results showing a 110% increase in PAT to 104 Crore, with a revenue rise of 37% to 1,934 Crore and an EBITDA margin improvement to 28%.

AI Assistant

Epigral Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.